Part-A: Curcumin: Introduction, structure, and physicochemical
attributes
1. Curcumin: historical background, introduction, structure, and
physicochemical attributes
2. Curcumin as a pharmaceutical leader
3. Chemical structure and molecular targets of curcumin for cancer
therapy
4. Structural features of curcumin and its effects on
cancer-related signaling pathways
5. An overview of cellular, molecular, and biological aspect(s) of
curcumin in cancer
Part-B: Smart drug delivery approaches for curcumin delivery in
cancer therapy
6. Curcumin-drug conjugate-based drug delivery as cancer
therapeutics
7. Curcumin microcapsule-based drug delivery as cancer
therapeutics
Part-C: Recent advances and regulatory aspects of gold
nanoparticles
8. Nanoemulsion-based curcumin delivery systems as cancer
therapeutics
9. Micelle-based curcumin delivery systems as cancer
therapeutics
10. Liposome-based curcumin delivery systems as cancer
therapeutics
11. Inorganic nanoparticle-based curcumin delivery as cancer
therapeutics
12. PLGA nanoparticle-based curcumin delivery as cancer
therapeutics
13. Polymersomes-based curcumin delivery as cancer therapeutics
Part-D: Recent advances in nanocurcumin delivery in cancer
therapy
14. Biopolymer-based formulations for curcumin delivery toward
cancer management
15. Nanohybrid drug delivery approach as a novel opportunity for
curcumin delivery in cancer
16. Codelivery of curcumin and siRNA as anticancer therapeutics
Part-E: Challenges and future perspectives of nano-curcumin drug
delivery
17. Challenges associated with nanocurcumin anticancer drug
delivery systems
18. Curcumin-loaded nanoparticles used for in vivo cancer models:
an approach about their physicochemical properties and mechanism of
action
19. Clinical trials, patents, and marketed products of
nanocurcumin-based anticancer drug delivery systems
Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic, experimental, and clinical research on curcuminoids. Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award, most prestigious “SERB-Ramanujan Fellowship Award. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.
|
Ask a Question About this Product More... |
|
